Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06742567 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction

Study acronym: POTAMI
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 19, 2024 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The objective of this randomized controlled trial is to compare the safety and efficacy of low dose Apixaban (2.5 mg bid) in addition to guideline directed medical therapy vs guideline directed medical therapy alone in the prevention of left ventricular thrombus formation (after 30-days) following primary PCI in patients with acute anterior myocardial infarction with severe LV dysfunction.
Trial Details
NCT Number NCT06742567
Lead Sponsor National Institute of Cardiovascular Diseases, Pakistan
Conditions
(from sponsor)		 Acute Myocardial Infarction of Anterior Wall, Left Ventricular Thrombus, Prophylaxis
Related terms Anterior Wall Myocardial Infarction, Ventricular Dysfunction, Left
Enrollment 472 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov